• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    ---
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesROTH
PharmaRoth Labs Inc
390.0
0.0x
---
United StatesPPCB
Propanc Biopharma Inc
52.1K
0.0x
---
United StatesNXGB
Nxgen Brands Inc
320.7K
0.0x
---
United StatesCLTS
Earth Life Sciences Inc
100.0K
-0.2x
---
United StatesSIGO
Sunset Island Group Inc
10.0
0.0x
---
United StatesMDCN
Medican Enterprises Inc
38.9K
0.0x
---
As of 2024-04-27

Company Information

PharmaRoth Labs, Inc. is a nutraceutical company that is focused on the prevention and treatment of healthcare diabetes. The Company is engaged in the production, marketing, and distribution of Sucanon, a clinically-tested herbal-based nutraceutical treatment for type II diabetes. Sucanon is a medication that helps the body make better use of its own insulin, the hormone that controls blood sugar levels.

Contact Information

Headquarters
8861 W. Sahara Ave., Suite 210LAS VEGAS, NV, United States 89117
Phone
212-541-6222
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer
Luis Lopez
Interim Chief Financial Officer
Barry Hall

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$390.00
Revenue (TTM)
$200.2K
Shares Outstanding
394.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-314.62%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.